Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Robert W. Baird assumed coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a research note released on ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...

HC Wainwright raised their FY2028 earnings per share (EPS) estimates for Denali Therapeutics in a report issued on Tuesday, January 7th. HC Wainwright analyst A. Fein now expects that the company will ...

Denali obtains Breakthrough Therapy Designation for its experimental candidate, tividenofusp alfa (DNL310), for the treatment of pateints with Hunter syndrome.

Following the negative Phase I trial outcome for its autoimmune disease treatment, the company is cutting 73% of jobs.

After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are ...

NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...

A methane gas explosion caused a mine collapse in southwest Pakistan, trapping at least 12 miners. Rescue operations are ongoing in the Balochistan province with no rescues yet. The incident ...

It’s unacceptable to describe NPP as micro-minority in Parliament - Afenyo-Markin protests Speaker’s description 08-01-25 ...